Simple Summary In this review, we discuss the different treatment strategies in recurrent
endometrial cancer. The incidence of endometrial cancer is rising. The available treatment …

Background Other than for breast cancer, endocrine therapy has not been highly effective for
gynecologic cancers. Endocrine therapy resistance in estrogen receptor positive …

Importance Patients with low-grade (ie, grade 1-2) endometrial cancer (EC) are
characterized by their favorable prognosis compared with patients with high-grade (ie, grade …

Background Advanced low‐grade ovarian carcinoma (LGOC) is difficult to treat. In several
studies, high estrogen receptor (ER) protein expression was observed in patients with …

Precision treatment of cancer requires knowledge on active tumor driving signal
transduction pathways to select the optimal effective targeted treatment. Currently only a …

Simple Summary Androgen receptor signaling seems pivotal in aggressive salivary duct
carcinoma. However, androgen deprivation therapy (ADT) frequently fails, emphasizing the …

A subset of endometrial endometrioid carcinomas (EECs) with low-grade histology recur
with poor outcomes. Published evidence suggests that poor outcomes may be associated …

Background Uterine corpus endometrial carcinoma (UCEC) is a common malignant cancer
type which affects the health of women worldwide. However, its molecular mechanism has …

Background Fifteen percent of patients with endometrial cancer (EC) have advanced stage
disease or develop a recurrence. Progestins have been applied as systemic treatment for …

Background Endometrioid adenocarcinoma (EAC) is the most common subtype of
endometrial cancer (EC) and is an estrogen-related cancer. In this study, we sought to …